US 8697836
Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response
granted A61KA61K2239/49A61K2239/50
Quick answer
US patent 8697836 (Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response) held by The Regents of the University of California expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2239/49, A61K2239/50, A61K2239/55, A61K2239/57